Navigation Links
The Only Chromogenic Medium That Detects Both Salmonella and Shigella!
Date:2/14/2011

SANTA MARIA, Calif., Feb. 14, 2011 /PRNewswire/ -- Hardy Diagnostics, an ISO certified biomedical firm, is pleased to announce the release of HardyCHROM™ SS, a highly selective chromogenic medium recommended for use as a primary screening medium for the isolation and differentiation of Salmonella and Shigella spp. from stool cultures. These two pathogens can be easily distinguished from non-pathogenic enteric bacteria based on colony color. Differentiation of Salmonella and Shigella spp. from non-pathogenic bacteria is accomplished by three mechanisms: chromogenic reactions, carbohydrate fermentation, and hydrogen sulfide production. Shigella and non-H2S producing Salmonella spp. appear as turquoise colonies. H2S producing Salmonella will develop colonies with black centers.

(Photo:  http://photos.prnewswire.com/prnh/20110214/LA44845)

HardyCHROM™ SS represents the first and only chromogenic culture medium that simultaneously detects both Salmonella and Shigella spp. while ruling out non-pathogenic enteric bacteria (both lactose and non-lactose-fermenting organisms). Most Proteus spp. do not produce black colonies (H2S) and do not produce a color change on this medium; and therefore are not confused with Salmonella and Shigella.

HardyCHROM™ SS provides superior differentiation of colonies, reduces the need for secondary testing of isolates, and thus results in less false-positive results.  HardyCHROM™ SS also allows the laboratory technologist to use fewer culture media plates when setting up stool cultures.

ABOUT HARDY DIAGNOSTICSHardy Diagnostics is an FDA licensed and ISO 13485 certified manufacturer of medical devices for microbiological procedures in both clinical and industrial laboratories. The company manufactures over 3,000 products for the culture and identification of bacteria and fungi from its Santa Maria, California headquarters. Currently over 6,000 laboratories are serviced by Hardy Diagnostics throughout the nation.

The company was founded in 1980 by Jay Hardy, a Clinical Laboratory Scientist from Santa Barbara, CA. Today, Hardy Diagnostics maintains six distribution centers throughout the U.S. and exports products to over 30 foreign distributors.

The company's mission is to partner with its laboratory customers to prevent and diagnose disease. For more information, visit http://www.HardyDiagnostics.com/HardyChromSS.htmlContact Information:Contact Person: Christopher CataniCompany Name: HARDY DIAGNOSTICSAddress: 1430 West McCoy Lane, Santa Maria, CA 93455Phone Number: (805) 346-2766, Ext: 5696Fax Number: (805) 928-2950Email Address: CataniC@HardyDiagnostics.comCompany Website: http://www.HardyDiagnostics.com/HardyChromSS.html
'/>"/>

SOURCE Hardy Diagnostics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New Chromogenic Endotoxin Detection System
2. QualTech Laboratories Validates USP Protocols for Anti-Factor IIa Chromogenic Assay for Potency
3. eCareSoft Launches Comprehensive EHR for Small & Medium Hospitals
4. PharMEDium Announces Propofol, Ready-to-Use, Single Patient, Syringe Service for Operating Room Anesthesia
5. PharMEDium Hires Thomas W. Rasnic as Vice President, Quality, Regulatory Affairs and Research and Development
6. PharMEDium Elects William R. Spalding to Board of Directors
7. Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam
8. New Small and Medium Sized Enterprises Join TI Pharma by Signing Two New Projects
9. Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System
10. Thermo Fisher Scientific Receives FDA Clearance for MRSA Test Medium
11. American Heart Association Rapid Access Journal Report: Implanted Monitor Accurately Detects Heart Rhythm Disturbances
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/16/2017)... -- Exactly 50 years ago today, the Monterey Pop Festival opened ... the San Francisco "Summer of Love."  To celebrate the anniversary, ... in strategic market research portals that it will begin delivering ... Northern Light,s "Summer of Love (For Our Customers)."  ... ...
(Date:6/14/2017)... , June 14, 2017  In 2016, Embodied ... Startups pitch competition and came away with $25,000 ... is described by Forbes as "entering the life of ... Association as teaching "empathy to medical professionals in an ... was recently named a finalist for the Department of ...
(Date:6/11/2017)...  Eli Lilly and Company (NYSE: LLY ) ... of galcanezumab, an investigational treatment for the prevention of ... key secondary endpoints for galcanezumab compared to placebo at ... EVOLVE-2 and REGAIN) will be presented today at the ... Boston . "The detailed ...
Breaking Medicine Technology:
(Date:6/27/2017)... ... June 27, 2017 , ... ... appointment of Mike Finnegan to the position of Executive Vice President, Sales and ... in healthcare technology, telehealth and medical device sales leadership. He has received industry ...
(Date:6/27/2017)... ... June 27, 2017 , ... ... many of the health care industry’s hospitals and provider groups, has announced that ... for select customers. Parasail Health is a San Francisco health-finance startup that has ...
(Date:6/27/2017)... ... June 27, 2017 , ... A January 18th article ... reach a staggering $6.81 billion by the year 2024 according to a new report. ... rate than those made from titanium. Los Angeles area clinic Beverly Hills Periodontics & ...
(Date:6/27/2017)... ... June 27, 2017 , ... Atmosera , ... Atmosera Managed Azure Services . The trusted, transparent, and secure solution for the ... growing customer base. Atmosera’s next generation services include integrated capabilities for public, private, ...
(Date:6/27/2017)... ... June 27, 2017 , ... Today, June 27th is ... PTSD. Yet less than 20% will receive adequate care due to lack of effective ... receive any care at all. And left untreated, veterans are at an increased risk ...
Breaking Medicine News(10 mins):